Amneal Pharmaceuticals releases dexamethasone and tobramycin ophthalmic suspension 0.3%/0.1% following US FDA approval. Dexamethasone and tobramycin ophthalmic suspension 0.3%/0.1% is the generic version of TobraDex, which is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.